NO20005041L - FremgangsmÕte for Õ inhibere MRP1 - Google Patents
FremgangsmÕte for Õ inhibere MRP1Info
- Publication number
- NO20005041L NO20005041L NO20005041A NO20005041A NO20005041L NO 20005041 L NO20005041 L NO 20005041L NO 20005041 A NO20005041 A NO 20005041A NO 20005041 A NO20005041 A NO 20005041A NO 20005041 L NO20005041 L NO 20005041L
- Authority
- NO
- Norway
- Prior art keywords
- procedure
- mrp1
- inhibiting mrp1
- inhibiting
- mediated
- Prior art date
Links
- 102100021339 Multidrug resistance-associated protein 1 Human genes 0.000 title abstract 2
- 108010066052 multidrug resistance-associated protein 1 Proteins 0.000 title abstract 2
- 230000002401 inhibitory effect Effects 0.000 title 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8108898P | 1998-04-08 | 1998-04-08 | |
| PCT/US1999/007615 WO1999051236A1 (en) | 1998-04-08 | 1999-04-07 | Methods for inhibiting mrp1 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20005041D0 NO20005041D0 (no) | 2000-10-06 |
| NO20005041L true NO20005041L (no) | 2000-10-06 |
Family
ID=22162031
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20005041A NO20005041L (no) | 1998-04-08 | 2000-10-06 | FremgangsmÕte for Õ inhibere MRP1 |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US6221876B1 (id) |
| EP (1) | EP1067932A4 (id) |
| JP (1) | JP2002510632A (id) |
| KR (1) | KR20010042481A (id) |
| CN (1) | CN1296410A (id) |
| AU (1) | AU3550299A (id) |
| BR (1) | BR9909446A (id) |
| CA (1) | CA2327452A1 (id) |
| EA (1) | EA200001035A1 (id) |
| HU (1) | HUP0102548A2 (id) |
| ID (1) | ID26804A (id) |
| IL (1) | IL138393A0 (id) |
| NO (1) | NO20005041L (id) |
| PL (1) | PL343320A1 (id) |
| SK (1) | SK14992000A3 (id) |
| TR (1) | TR200002804T2 (id) |
| WO (1) | WO1999051236A1 (id) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE315033T1 (de) | 1998-08-07 | 2006-02-15 | Chiron Corp | Subtituierte isoxazole derivate als estrogen rezeptor modulatore |
| WO2001046199A1 (en) * | 1999-12-22 | 2001-06-28 | Eli Lilly And Company | Methods and compounds for inhibiting mrp1 |
| US6743794B2 (en) | 1999-12-22 | 2004-06-01 | Eli Lilly And Company | Methods and compounds for inhibiting MRP1 |
| CA2411813A1 (en) * | 2000-06-14 | 2001-12-20 | Eli Lilly And Company | Tricyclic compounds as mrp1-inhibitors |
| WO2002081481A1 (en) * | 2001-04-09 | 2002-10-17 | Eli Lilly And Company | Compounds and methods for inhibiting mrp1 |
| CN1281210C (zh) * | 2003-11-29 | 2006-10-25 | 胡汛 | 五味子乙素在制备治疗肿瘤药物中的应用 |
| WO2005113004A2 (en) * | 2004-05-14 | 2005-12-01 | The Cleveland Clinic Founfation | Small molecule inhibitors for mrp1 and other multidrug transporters |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5182290A (en) * | 1991-08-27 | 1993-01-26 | Neurogen Corporation | Certain oxazoloquinolinones; a new class of GABA brain receptor ligands |
-
1999
- 1999-04-07 TR TR2000/02804T patent/TR200002804T2/xx unknown
- 1999-04-07 US US09/646,063 patent/US6221876B1/en not_active Expired - Fee Related
- 1999-04-07 CN CN99804797A patent/CN1296410A/zh active Pending
- 1999-04-07 WO PCT/US1999/007615 patent/WO1999051236A1/en not_active Ceased
- 1999-04-07 PL PL99343320A patent/PL343320A1/xx not_active Application Discontinuation
- 1999-04-07 BR BR9909446-0A patent/BR9909446A/pt not_active IP Right Cessation
- 1999-04-07 HU HU0102548A patent/HUP0102548A2/hu unknown
- 1999-04-07 ID IDW20002006A patent/ID26804A/id unknown
- 1999-04-07 AU AU35502/99A patent/AU3550299A/en not_active Abandoned
- 1999-04-07 EA EA200001035A patent/EA200001035A1/ru unknown
- 1999-04-07 CA CA002327452A patent/CA2327452A1/en not_active Abandoned
- 1999-04-07 EP EP99917359A patent/EP1067932A4/en not_active Withdrawn
- 1999-04-07 KR KR1020007011101A patent/KR20010042481A/ko not_active Withdrawn
- 1999-04-07 IL IL13839399A patent/IL138393A0/xx unknown
- 1999-04-07 SK SK1499-2000A patent/SK14992000A3/sk unknown
- 1999-04-07 JP JP2000542007A patent/JP2002510632A/ja not_active Withdrawn
-
2000
- 2000-10-06 NO NO20005041A patent/NO20005041L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| IL138393A0 (en) | 2001-10-31 |
| NO20005041D0 (no) | 2000-10-06 |
| ID26804A (id) | 2001-02-08 |
| CN1296410A (zh) | 2001-05-23 |
| PL343320A1 (en) | 2001-08-13 |
| EP1067932A1 (en) | 2001-01-17 |
| WO1999051236A1 (en) | 1999-10-14 |
| KR20010042481A (ko) | 2001-05-25 |
| CA2327452A1 (en) | 1999-10-14 |
| TR200002804T2 (tr) | 2001-02-21 |
| EP1067932A4 (en) | 2001-11-14 |
| BR9909446A (pt) | 2000-12-12 |
| JP2002510632A (ja) | 2002-04-09 |
| SK14992000A3 (sk) | 2001-06-11 |
| AU3550299A (en) | 1999-10-25 |
| EA200001035A1 (ru) | 2001-04-23 |
| US6221876B1 (en) | 2001-04-24 |
| HUP0102548A2 (hu) | 2001-11-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE316531T1 (de) | Kondensierte dihydrochinolinon-derivate zur hemmung von mrp1 | |
| DK0840732T3 (da) | Substituerede benzolactamforbindelser som substans P-antagonister | |
| NO20062950L (no) | 5,7-diaminopyrazolo `43-Dlpyrimidiner med PDE-5 inhiberende aktivitet | |
| DE69531623D1 (de) | Neue benzoxazole | |
| ATE231149T1 (de) | (1,8)-naphthyridinderivate derivate mit antiviraler wirkung | |
| CY1108567T1 (el) | Αντιθρομβωτικες ενωσεις | |
| PE20011085A1 (es) | Compuestos isoxazolquinolin o imidazolquinolin como inhibidores de la proteina resistente a multifarmacos | |
| IS5497A (is) | Bífenýlamidínafleiður | |
| NO20005041L (no) | FremgangsmÕte for Õ inhibere MRP1 | |
| EA200301317A1 (ru) | Производные аминохинолина и его применение в качестве лигандов аденозина a3 | |
| NO20005042L (no) | FremgangsmÕter for Õ inhibere MRP1 | |
| ATE323492T1 (de) | Piperazin- und homopiperazinderivate zur hemmung der zellenadhäsion und zelleninfiltration | |
| BR0212899A (pt) | Compostos orgânicos | |
| TR200002851T2 (tr) | MRP1'i inhibe etmek için yöntemler. | |
| DE60041001D1 (de) | Substituierte homopiperidylbenzimidazolanaloga als fundusrelaxantien | |
| IL166164A0 (en) | 6-amino-1h-indazole and 4-aminobenzofuran compounds as phosphodiesterase 4 inhibitors | |
| DK1163258T3 (da) | Derivater af 22R-hydroxycholesta-8, 14-dien til inhiberingen af meiosis | |
| DK0963998T3 (da) | Azasteroidforbindelse til behandling eller prævention af prostatacancer | |
| DK1192191T3 (da) | Fremgangsmåde til fremstilling af kondensationsforbindelser | |
| ECSP982576A (es) | Derivados de epotilona | |
| CA2335685A1 (en) | Benflumetol derivatives, intermediates thereof and their use against parasitical protozoa and trematodes | |
| ATE189813T1 (de) | Prostaglandin-i-analoga | |
| ATE299883T1 (de) | Verbindungen und methoden zur hemmung von mrp1 | |
| ATE311392T1 (de) | Verbindungen und methoden zur inhibierung von mrp1 | |
| YU15395A (sh) | Antitrombonski agensi |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |